Viking Therapeutics Inc. on Wednesday reported positive data from an early-stage trial of a treatment for the rare, and often ...

In the latest trading session, Viking Therapeutics, Inc. (VKTX) closed at $62.45, marking a -0.3% move from the previous day. The stock trailed the S&P 500, which registered a daily loss of 0.21%.

Analyst Naz Rahman of Maxim Group reiterated a Buy rating on Viking Therapeutics (VKTX – Research Report), retaining the price target of ...

Viking Therapeutics (VKTX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst ...

Viking Therapeutics Inc.’s stock rose 1.4% in premarket trade Wednesday, after the biotech reported positive data from an early-stage trial of a treatme ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Viking Therapeutics (NASDAQ: VKTX) has captured the attention of investors, with its stock price skyrocketing over 400% in ...

Typically, for a biotech that's become popular, Viking's share price has hit a few peaks recently. Let's see if we can gauge ...

On Monday, Viking Therapeutics Inc (VKTX) stock saw a decline, ending the day at $63.01 which represents a decrease of $-1.95 or -3.00% from the prior close of $64.96. The stock opened at $65.61 and ...

Viking Therapeutics VKTX has outperformed the market over the past 5 years by 41.66% on an annualized basis producing an ...

Viking Therapeutics (NASDAQ: VKTX) has captured the attention of investors, with its stock price skyrocketing over 400% in one year. This remarkable performance stems from the company's promising ...